Glucagon-cortisol interactions on glucose turnover and lactate gluconeogenesis in normal humans.

To determine the mechanism for cortisol enhancement of glucagon-stimulated overall hepatic glucose output (OHGO), we employed the glucose-insulin clamp technique with infusions of [6-3H]glucose and [U-14C]lactate and measured OHGO, glucose utilization, and the turnover and incorporation of lactate in plasma glucose in normal volunteers under four experimental conditions: 1) normoglucagonemia (approximately 150 pg/ml)- normocortisolemia (approximately 14 micrograms/dl); 2) isolated hyperglucagonemia (approximately 550 pg/ml); 3) isolated hypercortisolemia (approximately 32 micrograms/dl); and 4) combined hyperglucagonemia-hypercortisolemia. Isolated hyperglucagonemia caused initial increases in OHGO and lactate gluconeogenesis, which were maximal at 1 h (23.9 +/- 1 and 2.7 +/- 0.4 mumol.kg-1.min-1, respectively) but remained significantly above values in control experiments through 5 h (10.3 +/- 0.7 vs. 8.2 +/- 1.1, P less than 0.03; 2.2 +/- 0.4 vs. 1.2 +/- 0.3, mumol.kg-1.min-1, P less than 0.04, respectively). Hypercortisolemia has no effect on OHGO but increased lactate gluconeogenesis after 3 h. Superimposition of hypercortisolemia on hyperglucagonemia did not further increase OHGO (11.1 +/- 0.7 vs. 10.3 +/- 0.7 mumol.kg-1.min-1, P = NS) but augmented lactate gluconeogenesis additively (isolated hyperglucagonemia = 0.96, isolated hypercortisolemia = 0.98; combined = 2.02 mumol.kg-1.min-1). Neither glucagon nor cortisol affected lactate turnover or glucose utilization. We conclude that glucagon has a persistent effect on OHGO largely accounted for by increased gluconeogenesis. Cortisol augments glucagon-stimulated gluconeogenesis in an additive manner best explained by changes in gluconeogenic enzymes rather than in substrate availability. Finally, the fact that cortisol increased gluconeogenesis without affecting glucose utilization suggests that the liver is more sensitive to the diabetogenic effects of cortisol than are peripheral tissues.

[1]  R. Rizza,et al.  Effects of glucocorticoids on carbohydrate metabolism. , 1988, Diabetes/metabolism reviews.

[2]  R. DeFronzo,et al.  Hyperglucagonemia and insulin-mediated glucose metabolism. , 1987, The Journal of clinical investigation.

[3]  P. Brunetti,et al.  Role of hepatic autoregulation in defense against hypoglycemia in humans. , 1985, The Journal of clinical investigation.

[4]  N. Kraus-Friedmann.  Hormonal regulation of hepatic gluconeogenesis. , 1984, Physiological reviews.

[5]  L. Mandarino,et al.  Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. , 1982, The Journal of clinical endocrinology and metabolism.

[6]  R. Sherwin,et al.  Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. , 1981, The Journal of clinical endocrinology and metabolism.

[7]  G. Shulman,et al.  Differential Time Course of Glucagon's Effect on Glycogenolysis and Gluconeogenesis in the Conscious Dog , 1981, Diabetes.

[8]  A. Cherrington,et al.  Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man. , 1979, The Journal of clinical endocrinology and metabolism.

[9]  N Eigler,et al.  Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia. , 1979, The Journal of clinical investigation.

[10]  R. Sherwin,et al.  Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones. , 1978, The Journal of clinical endocrinology and metabolism.

[11]  A. Cherrington,et al.  Persistent stimulatory effect of glucagon on glucose production despite downregulation. , 1978, The Journal of clinical endocrinology and metabolism.

[12]  H. Kuzuya,et al.  Characterization of Seven C-peptide Antisera , 1978, Diabetes.

[13]  R. Sherwin,et al.  The Lilly Lecture 1976: Insulin, Glucagon, and Somatostatin in Normal Physiology and Diabetes Mellitus , 1976, Diabetes.

[14]  P. Felig,et al.  Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man. , 1976, The Journal of clinical investigation.

[15]  W. C. Owen,et al.  Alanine and gluconeogenesis in man: effect of ethanol. , 1972, The Journal of clinical endocrinology and metabolism.

[16]  T. B. Miller,et al.  The hormonal control of hepatic gluconeogenesis. , 1970, Recent progress in hormone research.

[17]  B. Murphy,et al.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. , 1967, The Journal of clinical endocrinology and metabolism.

[18]  V. Herbert,et al.  Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.